Logo image of CPTK

CROWN PROPTECH ACQUISITION-A (CPTK) Stock Fundamental Analysis

NYSE:CPTK - New York Stock Exchange, Inc. - KYG257411028 - Common Stock - Currency: USD

10.78  +0.08 (+0.75%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to CPTK. CPTK was compared to 0 industry peers in the Unkown industry. Both the profitability and financial health of CPTK have multiple concerns. CPTK is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

CPTK had positive earnings in the past year.
CPTK had a negative operating cash flow in the past year.
CPTK Yearly Net Income VS EBIT VS OCF VS FCFCPTK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 0 5M -5M 10M

1.2 Ratios

Industry RankSector Rank
ROA 26.89%
ROE 28.78%
ROIC N/A
ROA(3y)1.46%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CPTK Yearly ROA, ROE, ROICCPTK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 0 2 -2 4 -4 -6

1.3 Margins

CPTK does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CPTK Yearly Profit, Operating, Gross MarginsCPTK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022

More info and screens

2

2. Health

2.1 Basic Checks

The number of shares outstanding for CPTK remains at a similar level compared to 1 year ago.
CPTK has a worse debt/assets ratio than last year.
CPTK Yearly Shares OutstandingCPTK Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 10M 20M 30M
CPTK Yearly Total Debt VS Total AssetsCPTK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 50M 100M 150M 200M 250M

2.2 Solvency

CPTK has an Altman-Z score of 24.16. This indicates that CPTK is financially healthy and has little risk of bankruptcy at the moment.
CPTK has a Debt/Equity ratio of 0.02. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Altman-Z 24.16
ROIC/WACCN/A
WACCN/A
CPTK Yearly LT Debt VS Equity VS FCFCPTK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 0 50M 100M 150M 200M 250M

2.3 Liquidity

CPTK has a Current Ratio of 0.06. This is a bad value and indicates that CPTK is not financially healthy enough and could expect problems in meeting its short term obligations.
A Quick Ratio of 0.06 indicates that CPTK may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.06
Quick Ratio 0.06
CPTK Yearly Current Assets VS Current LiabilitesCPTK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 1M 2M 3M 4M

More info and screens

1

3. Growth

3.1 Past

CPTK shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 457.14%, which is quite impressive.
EPS 1Y (TTM)457.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%700%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CPTK Yearly Revenue VS EstimatesCPTK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022
CPTK Yearly EPS VS EstimatesCPTK Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 27.64 indicates a quite expensive valuation of CPTK.
CPTK's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 29.62.
Industry RankSector Rank
PE 27.64
Fwd PE N/A
CPTK Price Earnings VS Forward Price EarningsCPTK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CPTK Per share dataCPTK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CPTK!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CROWN PROPTECH ACQUISITION-A

NYSE:CPTK (2/9/2024, 8:04:00 PM)

10.78

+0.08 (+0.75%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners1.8%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap119.66M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 27.64
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 2.91
P/tB 2.91
EV/EBITDA N/A
EPS(TTM)0.39
EY3.62%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.09
FCFYN/A
OCF(TTM)-0.09
OCFYN/A
SpS0
BVpS3.7
TBVpS3.7
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 26.89%
ROE 28.78%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)1.46%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.06
Quick Ratio 0.06
Altman-Z 24.16
F-Score7
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)457.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%700%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y76.8%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y76.19%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y76.19%
OCF growth 3YN/A
OCF growth 5YN/A